Dexmedetomidine and Clonidine Inhibit Ventricular Tachyarrhythmias in a Rabbit Model of Acquired Long QT Syndrome

Circulation Journal

Volumn 76, Issue 10, 2012, Pages 2343-2347

  Tsutsui, Kenta ^a   Hayami, Noriyuki ^a   Kunishima, Tomoyuki ^a   Sugiura, Anna ^a   Mikamo, Takashi ^a   Kanamori, Kenta ^a   Yamagishi, Noboru ^a   Yamagishi, Satoshi ^a   Watanabe, Hidenori ^a   Ajiki, Kosuke ^a   Murakawa, Yuji ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clonidine; Dexmedetomidine; Early afterdepolarization; Methoxamine; Nifekalant

Indexed keywords

CLONIDINE; DEXMEDETOMIDINE; METHOXAMINE; NIFEKALANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART RATE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; INCIDENCE; LONG QT SYNDROME; NONHUMAN; QT INTERVAL; RABBIT; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CLONIDINE; DEXMEDETOMIDINE; DISEASE MODELS, ANIMAL; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; METHOXAMINE; PYRIMIDINONES; RABBITS; TACHYCARDIA;

EID: 84867848923     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0171     Document Type: Article

References (15)

1. Hayashi Y, Sumikawa K, Maze M, Yamatodani A, Kamibayashi T, Kuro M, et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha 2 adrenoreceptors in halothane-anesthetized dogs. Anesthesiology 1991; 75: 113-117.
2. Parent BA, Munoz R, Shiderly D, Chrysostomou C. Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care 2010; 38: 781.
3. 2+ current in ventricular cardiomyocytes. J Mol Cell Cardiol 2010; 48: 26-36.
4. Lankipalli RS, Zhu T, Guo D, Yan GX. Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol 2005; 38: 69-73.
5. Carlsson L, Abrahamsson C, Drews L, Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 1992; 85: 1491-1500.
6. Inaba H, Hayami N, Ajiki K, Sugishita Y, Kunishima T, Yamagishi N, et al. Human atrial natriuretic peptide suppresses torsades de pointes in rabbits. Circ J 2008; 72: 820-824.
7. Inaba H, Hayami N, Ajiki K, Kunishima T, Watanabe H, Tsutsui K, et al. Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome. Circ J 2011; 75: 89-93.
8. Talke PO, Lobo E, Brown R. Systemically administered alpha2-agonist- induced peripheral vasoconstriction in humans. Anesthesiology 2003; 99: 65-70.
9. Indolfi C, Piscione F, Villari B, Russolillo E, Rendina V, Golino P, et al. Role of alpha 2 adrenoreceptors in normal and atherosclerotic human coronary circulation. Circulation 1992; 86: 1116-1121.
10. Baumgart D, Haude M, Görge G, Liu F, Ge J, Grosse-Eggebrecht C, et al. Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999; 99: 2090-2097.
11. Figueroa XF, Poblete MI, Boric MP, Mendizábal VE, Adler-Graschinsky E, Huidobro-Toro JP. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoreceptor activation. Br J Pharmacol 2001; 134: 957-968.
12. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273: 803-805.
13. Shimizu S, Akiyama T, Kawada T, Sata Y, Mizuno M, Kamiya A, et al. Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control. Circ J 2012; 76: s152-s159.
14. Masuki S, Dinenno FA, Joyner MJ, Eisenach JH. Selective alpha2- adrenergic properties of dexmedetomidine over clonidine in the human forearm. J Appl Physiol 2005; 99: 587-592.
15. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: A meta-analysis. Intensive Care Med 2010; 36: 926-939.